Company News in the Life Science Industry

»

Reset 

China 2020: Coronavirus Outbreak to Drive the Air Treatment Systems Market, Exceeding $6 Billion by 2026

DUBLIN, March 25, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 25 Mar 2020

PracticeSuite Deploys Secure Telehealth Platform for Providers, Making the Module Available Free To The Worldwide Healthcare Community

Read more ››
By: GlobenewsWire - 25 Mar 2020

HTG Molecular Diagnostics Reports Full Year 2019 Results

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  HTG Molecular Diagnostics, Inc.

Ascendis Pharma A/S Announces Full Year 2019 Financial Results and Business Update Conference Call on April 1

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  Ascendis Pharma A/S

Agios Provides Update on 2016 Collaboration Agreement with Celgene, a Wholly Owned Subsidiary of Bristol Myers Squibb

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  Agios Pharmaceuticals, Inc.

CytomX Therapeutics Announces New Employment Inducement Grant

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  CytomX Therapeutics, Inc.

Eyenovia Reports Fourth Quarter and Full Year 2019 Financial Results

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  Eyenovia, Inc.

Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  Exagen Diagnostics, Inc.

89bio Appoints Healthcare Industry Veteran Steven Altschuler, M.D., as Chairman of the Board of Directors

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  89bio, Inc.

ProQR to Present Findings from Phase 1/2 Interim Analysis of QR-421a for Usher Syndrome

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  ProQR Therapeutics NV

Viela Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  Viela Bio, Inc.

Altimmune to Announce Year End 2019 Financial Results on March 27

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  Altimmune, Inc.

Kane Biotech Reschedules Release of Fourth Quarter and Full Year 2019 Financial Results and Associated Conference Call to April 2, 2020

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  Kane Biotech Inc.

Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19

Read more ››
By: GlobenewsWire - 25 Mar 2020

Plus Therapeutics To Report Fourth Quarter and Full Fiscal Year 2019 Financial Results and Corporate Update on March 30, 2020

Read more ››
By: GlobenewsWire - 25 Mar 2020

Orexo Has Repurchased 14 Percent of Own Corporate Bonds

UPPSALA, Sweden, March 25, 2020 /PRNewswire/ -- Orexo AB (publ.) has repurchased 14 percent of its outstanding unsecured corporate bonds with a nominal value of SEK 40,500,000 through several purchases on the market. The repurchase concerns unsecured corporate bonds with ISIN SE0010494450 and... Read more ››

By: PR Newswire Association LLC. - 25 Mar 2020
Related companies:  Orexo AB

Specialty Renal Products Announces Appointment of Tony Robinson as Vice President of Operations

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  Nephros, Inc.

MPX INTERNATIONAL ANNOUNCES POSTPONEMENT OF ANNUAL MEETING OF SHAREHOLDERS

Read more ››
By: GlobenewsWire - 25 Mar 2020

BioSig subsidiary NeuroClear acquires license for a broad-spectrum anti-viral agent that may treat COVID-19. Laboratory results demonstrate high level of activity against COVID-19 in cell culture

Read more ››
By: GlobenewsWire - 25 Mar 2020
Related companies:  BioSig Technologies, Inc.

MediPharm Labs Ships Cannabis Topicals and Accelerates Development to Expand Topicals Presence in Medical and Adult-Use Markets

Read more ››
By: GlobenewsWire - 25 Mar 2020
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies